Literature DB >> 9014771

Detection of adenocarcinoma in Barrett's oesophagus by means of laser induced fluorescence.

C S von Holstein1, A M Nilsson, S Andersson-Engels, R Willén, B Walther, K Svanberg.   

Abstract

PATIENTS: Seven patients with Barrett's metaplastic epithelium and oesophageal adenocarcinoma were investigated by means of laser induced fluorescence after low dose intravenous injection (0.35 mg/kg bw) of Photofrin (QLT, Vancouver, Canada). Laser induced fluorescence measurements were performed immediately after resection of the oesophagus.
METHODS: Laser induced fluorescence spectra were recorded from 15-30 locations in each surgical specimen from normal mucosa, Barrett's epithelium, and tumour tissue. Histological examination was performed on each location to correlate the fluorescence spectral characteristics with histological status of the epithelium (normal, metaplastic or malignant). Measurements were also performed during endoscopy in five patients to test the applicability of the method in a clinical setting. Fluorescence spectra were recorded and evaluated at characteristic wavelengths, and biopsy specimens were collected. Fluorescence ratios were calculated as the quotient of Photofrin fluorescence divided by autofluorescence.
RESULTS: The mean (SD) fluorescence ratio values were 0.10 (0.058) for normal oesophageal mucosa, 0.16 (0.073) for normal gastric mucosa, 0.205 (0.17) for Barrett's epithelium with moderate dysplasia, 0.79 (0.54) for severe dysplasia, and 0.78 (0.56) for adenocarcinoma. The highest fluorescence ratios were obtained for adenocarcinoma tissue, which could generally be distinguished from all nonmalignant tissue. Metaplastic Barrett's epithelium also yielded higher fluorescence ratios than did normal mucosa.
CONCLUSIONS: The results suggest that the technique can be used during endoscopy for real time tissue characterisation in the oesophagus, as an aid in detecting malignant transformation not macroscopically apparent at endoscopy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9014771      PMCID: PMC1383396          DOI: 10.1136/gut.39.5.711

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

1.  Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions.

Authors:  B J Reid; W M Weinstein; K J Lewin; R C Haggitt; G VanDeventer; L DenBesten; C E Rubin
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

Review 2.  Barrett's esophagus.

Authors:  S J Spechler; R K Goyal
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

Review 3.  Barrett's esophagus: a review.

Authors:  R W Sjogren; L F Johnson
Journal:  Am J Med       Date:  1983-02       Impact factor: 4.965

4.  The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus.

Authors:  A J Cameron; B J Ott; W S Payne
Journal:  N Engl J Med       Date:  1985-10-03       Impact factor: 91.245

5.  Adenocarcinoma in the distal esophagus with and without Barrett esophagus. Differences in symptoms and survival rates.

Authors:  J Johansson; F Johnsson; B Walther; R Willén; C Staël von Holstein; T Zilling
Journal:  Arch Surg       Date:  1996-07

6.  Detection of early lung cancer using low dose Photofrin II.

Authors:  S Lam; B Palcic; D McLean; J Hung; M Korbelik; A E Profio
Journal:  Chest       Date:  1990-02       Impact factor: 9.410

7.  Laser-induced fluorescence spectroscopy of human colonic mucosa. Detection of adenomatous transformation.

Authors:  C R Kapadia; F W Cutruzzola; K M O'Brien; M L Stetz; R Enriquez; L I Deckelbaum
Journal:  Gastroenterology       Date:  1990-07       Impact factor: 22.682

8.  Barrett's esophagus: development of dysplasia and adenocarcinoma.

Authors:  W Hameeteman; G N Tytgat; H J Houthoff; J G van den Tweel
Journal:  Gastroenterology       Date:  1989-05       Impact factor: 22.682

9.  Dysplasia in Barrett's esophagus.

Authors:  H G Schmidt; R H Riddell; B Walther; D B Skinner; J F Riemann
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

10.  Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus.

Authors:  C S Robertson; J F Mayberry; D A Nicholson; P D James; M Atkinson
Journal:  Br J Surg       Date:  1988-08       Impact factor: 6.939

View more
  9 in total

Review 1.  Barrett's oesophagus.

Authors:  R M Navaratnam; M C Winslet
Journal:  Postgrad Med J       Date:  1998-11       Impact factor: 2.401

2.  Era of Barrett's surveillance: does equipment matter?

Authors:  Jayan Mannath; Krish Ragunath
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

3.  Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques.

Authors:  K Egger; M Werner; A Meining; R Ott; H-D Allescher; H Höfler; M Classen; T Rösch
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

Review 4.  Endoscopic evaluation and advanced imaging of Barrett's esophagus.

Authors:  Kenneth K Wang; Ngozi Okoro; Ganapathy Prasad; Michel WongKeeSong; Navtej S Buttar; Jianmin Tian
Journal:  Gastrointest Endosc Clin N Am       Date:  2011-01

5.  Spectrofluorimetric detection of DMBA-induced mouse skin carcinoma.

Authors:  K Karthikeyan; V Masilamani; S Govindasamy
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

6.  Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitisation.

Authors:  E Endlicher; R Knuechel; T Hauser; R M Szeimies; J Schölmerich; H Messmann
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

Review 7.  Tracing the "at-risk" oral mucosa field with autofluorescence: steps toward clinical impact.

Authors:  Catherine F Poh; Calum E MacAulay; Lewei Zhang; Miriam P Rosin
Journal:  Cancer Prev Res (Phila)       Date:  2009-04-28

Review 8.  Improving endoscopic resolution and sampling: fluorescence techniques.

Authors:  C Ell
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

Review 9.  Optical endomicroscopy and the road to real-time, in vivo pathology: present and future.

Authors:  Charles S Carignan; Yukako Yagi
Journal:  Diagn Pathol       Date:  2012-08-13       Impact factor: 2.644

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.